우리나라에서 확보한 해양미생물과 미세조류에 대한 기초생리활성 연구 = A Study on the Bioactivity Exploration of the Collected Marine Microorganisms and Microalgaes in Korea

국문 초록 (Abstract)

우리나라 여러 해양환경 지역으로부터 확보한 370주의 해양세균, 균류, 미세조류로부터 기초생리활성(항산화, 항염, 항균, 항암, 항바이러스)을 조사하여 채집지, 분리원, 종(種) 수준에서의 활성결과를 비교하였다. 해양세균의 경우, 일반적으로 유용성이 많이 알려진 Streptomyces 속과 Bacillus 속에 속하는 균주들이 두드러진 강한 효능이 관찰되었고, 주로 해양퇴적물로부터 유용한 자원을 분리할 수 있었다. 해양균류와 미세조류의 경우에도 종 특이적으로 활성이 강하게 나타나는 결과를 확인할 수 있었고, 효능 특이적으로 활성을 보이는 결과도 얻을 수 있었다. 이러한 결과를 바탕으로 추후 특정질병에 선택적으로 효능을 보이는 화학물질 연구 또는 자원 기반 연구 수행 시 유용성을 전제로 한 자원 확보 전략 수립과 산업 활성화를 위한 전략소재로 우선적 접근이 용이할 수 있는 연구결과라 생각된다. 또한, 이들 결과를 해양바이오 뱅크를 통한 분양소재로 활용함으로써 학계, 산업계에서 활용하여 해양바이오산업 활성화에 좀 더 빠른 접근을 도울 수 있다고 생각한다.

다국어 초록 (Multilingual Abstract)

Basic bioactivities (antioxidant, anti-inflammatory, antibacterial, anticancer, antiviral) were investigated from 370 strains of marine bacteria, fungi, and microalgae obtained from various marine environmental regions in Korea, and the activity results were obtained at the collection site, isolation source, and species level was compared. In the case of marine bacteria, strains belonging to the generally useful genera Streptomyces and Bacillus were observed to have particularly strong efficacy and useful resources were mainly isolated from marine sediments. In the case of marine fungi and microalgae, results showing strong species-specific activity were confirmed, and results showing efficacy-specific activity were also obtained. Based on these results, it is a research result that can facilitate priority access as a strategic material for industrial revitalization and the establishment of a strategy to secure resources based on usefulness when conducting research on chemicals that are selectively effective against specific diseases or when conducting resource-based research. In addition, we believe that by using these results as material for sale through the Marine BioBank(MBB), academia and industry can use them to help accelerate the revitalization of the marine bio industry.

참고문헌 (Reference)

• 1 Petersen LE, "YOUMARES 9 – The Oceans: our research, our future" 159-180, 2019
• 2 Quinn GA, "Streptomyces from traditional medicine : Sources of new innovations in antibiotic discovery" 69 : 1040-1048, 2020
• 3 Donald L, "Streptomyces : Still the biggest producer of new natural secondary metabolites, a current perspective" 13 : 418-465, 2022
• 4 Kwon YM, "Nonlabens antarcticus sp. nov., a psychrophilic bacterium isolated from glacier ice, and emended descriptions of Nonlabens marinus Park et al 2012 and Nonlabens agnitus Yi and Chun 2012" 64 : 400-405, 2014
• 5 Strom SL, "Microbial ecology of ocean biogeochemistry : a community perspective" 320 : 1043-1045, 2008
• 6 Mayer AM, "Marine pharmacology in 2000 : marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiuberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action" 6 : 37-52, 2004
• 7 Faulkner DJ, "Marine natural products" 19 : 1-48, 2002
• 8 Blunt JW, "Marine natural products" 32 : 116-211, 2015
• 9 Kumar S, "MEGA X : molecular evolutionary genetics analysis across computing platforms" 35 : 1547-1549, 2018
• 10 Dawoon Chung ; Kyunghwa Baek ; Seung Seob Bae ; 정재준, "Identification and characterization of a marine-derived chitinolytic fungus, Acremonium sp. YS2-2" 한국미생물학회 57 (57): 372-380, 2019
• 11 Guiry MD, "How many species of algae are there?" 48 : 1057-1063, 2012
• 12 Ramos DF, "Chemical profile and antimicrobial activity of the marine diatom Chaetoceros muelleri" 19 : e202100846-, 2022
• 13 Falkowski PG, "Aquatic Photosynthesis" Princeton University Press 2007
• 14 Blois MS, "Antioxidant determinations by the use of a stable free radical" 181 : 1199-1200, 1958
• 15 Re R, "Antioxidant activity applying an improved ABTS radical cation decolorization assay" 26 : 1231-1237, 1999